Zurich, Switzerland, December 03, 2025 – MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive topline results from the Phase 2 clinical trial SUISSE-MPC2 (NCT05534269) ...
A Class IX student tragically passed away from burn injuries after allegedly setting herself ablaze due to harassment by three teachers. The 13-year-old, in a video released by her family, accused her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback